Introduction: Limited data suggest that closure of a patent foramen ovale (PFO) may be more effective in preventing stroke in men than in women. We aimed to assess sex-based differences in long-term ...

TCT 1403: Use of the “Tootsie Roll Technique” to Occlude an Aortic Annular Pseudoaneurysm and Paravalvular Leak After Transcatheter Aortic Valve Replacement Receive the the latest news, research, and ...

Flaherty & Crumrine Preferred Income Opportunity Fund remains a buy, offering a 6.3% yield and trading at a 6.54% discount to NAV. PFO provides diversified exposure to preferred securities, with a ...

Department of Structural Heart Disease, Fuwai Hospital & National Center for Cardiovascular Disease, Key Laboratory of Innovative Cardiovascular Devices, Chinese Academy of Medical Sciences & Peking ...

St. Luke's Health-Memorial Hospital Lufkin recently announced a significant advancement in cardiovascular care, becoming the first and only hospital in Deep East Texas to successfully perform a ...

I rate PFO a buy due to its attractive discount to NAV and a compelling 6.6% dividend yield for income-focused investors. PFO's performance is highly sensitive to interest rates; future rate cuts ...

Among patients aged older than 60 years in the US, patent foramen ovale closure decreases risk for recurrent ischemic stroke. Patent foramen ovale (PFO) closure decreases recurrent ischemic stroke (IS ...

Cardiovalve has beaten Edwards Lifesciences in a patent spat over transcatheter heart valve technologies. In a ruling this week, the U.S. Court of Appeals for the Federal Circuit sided with ...

Randomized trials have shown the efficacy of transcatheter closure of patent foramen ovale (PFO) in patients aged ≤ 60 years with cryptogenic embolism. We aimed to assess the long-term safety and ...